AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32606212 — intervention group
Group type: EXPERIMENTAL
Intervention: User-tested guidelines
Number of subjects: 273
Study 32606212 — intervention group
Group type: COMPARATOR
Intervention: Current guidelines
Number of subjects: 273
Study 32960536 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (AT; prophylactic antibiotics and steroids)
Number of subjects: 43
Study 32960536 — intervention group
Group type: COMPARATOR
Intervention: No treatment (AT-free group)
Number of subjects: 43
Study 32960536 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (AT)
Number of subjects: 43
Study 36281094 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intravenous fluid loading with Ringer's lactate solution
Number of subjects: 171
Study 36281094 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 171
Study 36281094 — intervention group
Group type: COMPARATOR
Intervention: Control (neither fluid nor ondansetron)
Number of subjects: 171
Study 33638801 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (140 mg subcutaneously injected once before revascularization + 14 days after the first dose)
Number of subjects: 530
Study 33638801 — intervention group
Group type: COMPARATOR
Intervention: Control group (no evolocumab injection)
Number of subjects: 530
Study 33638801 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 530
Study 33638801 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 530
Study 35615730 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound-guided biopsy
Number of subjects: 110
Study 35615730 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided biopsy
Number of subjects: 110
Study 35615730 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound-guided biopsy (≥30 mm lesions)
Number of subjects: 110
Study 35615730 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided biopsy (≥30 mm lesions)
Number of subjects: 110
Study 35615730 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound-guided biopsy (<30 mm lesions)
Number of subjects: 110
Study 35615730 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound-guided biopsy (<30 mm lesions)
Number of subjects: 110
Study 33314799 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 76
Study 33314799 — intervention group
Group type: COMPARATOR
Intervention: Mock laser acupuncture (ML)
Number of subjects: 76
Study 32541773 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Nitric Oxide (iNO) 160 ppm plus oxygen/air for 30 min, five times/day, up to 5 days
Number of subjects: 69
Study 32541773 — intervention group
Group type: COMPARATOR
Intervention: Control: oxygen/air alone
Number of subjects: 69
Study 34883305 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry intake (26 g freeze-dried blueberries)
Number of subjects: 45
Study 34883305 — intervention group
Group type: COMPARATOR
Intervention: Placebo (26 g isocaloric matched placebo)
Number of subjects: 45
Study 33682064 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory of Mind (ToM) training conducted by nursing home operators
Number of subjects: 0
Study 33682064 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 32239237 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based screening for fracture risk
Number of subjects: 1000
Study 32239237 — intervention group
Group type: COMPARATOR
Intervention: Usual management
Number of subjects: 1000
Study 35276667 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 0
Study 35276667 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 35275043 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercapnic hypoxia respiratory exercises (20 minutes per day, 14 to 16 sessions)
Number of subjects: 42
Study 35275043 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercapnic hypoxia respiratory exercises
Number of subjects: 42
Study 32990454 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy (DPT)
Number of subjects: 60
Study 32990454 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study 33580319 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green fluorescence angiography (ICG‐FA) with PINPOINT®
Number of subjects: 100
Study 33580319 — intervention group
Group type: COMPARATOR
Intervention: Non-perfusion
Number of subjects: 100
Study 33580319 — intervention group
Group type: COMPARATOR
Intervention: Diabetes
Number of subjects: 100
Study 32311079 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated measures random forest (RMRF) algorithm
Number of subjects: 127
Study 32311079 — intervention group
Group type: EXPERIMENTAL
Intervention: RMRF algorithm
Number of subjects: 127
Study 32307669 — intervention group
Group type: EXPERIMENTAL
Intervention: One Anastomosis Gastric Bypass (OAGB)
Number of subjects: 491
Study 32307669 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 491
Study 37170922 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg subcutaneously every 2 weeks
Number of subjects: 30
Study 37170922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 37170922 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 30
Study 33316426 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy plus completion lymph node dissection (CLND)
Number of subjects: 2305
Study 33316426 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node (SLN) biopsy without completion lymph node dissection (CLND)
Number of subjects: 2305
Study 33316426 — intervention group
Group type: EXPERIMENTAL
Intervention: N2a disease
Number of subjects: 2305
Study 32841904 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperarousal symptoms
Number of subjects: 247
Study 32841904 — intervention group
Group type: EXPERIMENTAL
Intervention: Reexperiencing and avoidance symptoms
Number of subjects: 247
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: MTV calculated using SUV4.0 threshold
Number of subjects: 107
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: TLG calculated using SUV4.0 threshold
Number of subjects: 107
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: MTV calculated using SUV140%L threshold
Number of subjects: 107
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: TLG calculated using SUV140%L threshold
Number of subjects: 107
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: MTV calculated using SUV41% threshold
Number of subjects: 107
Study 35717166 — intervention group
Group type: EXPERIMENTAL
Intervention: TLG calculated using SUV41% threshold
Number of subjects: 107
Study 34085953 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (plasma glucose < 3.0 mmol/L)
Number of subjects: 21
Study 34085953 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia
Number of subjects: 21
Study 34085953 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from hypoglycemia
Number of subjects: 21
Study 33777424 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 67
Study 33777424 — intervention group
Group type: COMPARATOR
Intervention: Non-directive counselling
Number of subjects: 67
Study 35351205 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised physiotherapy intervention
Number of subjects: 91
Study 35351205 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-individualised intervention
Number of subjects: 91
Study 35351205 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 91
Study 33724883 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg daily of canagliflozin
Number of subjects: 1900
Study 33724883 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1900
Study 34987499 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood mononuclear cells (PBMC) cultured and stimulated in vitro (n=68)
Number of subjects: 200
Study 34987499 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma analysis for inflammatory markers (n=200)
Number of subjects: 200
Study 34987499 — intervention group
Group type: EXPERIMENTAL
Intervention: Chalder Fatigue Questionnaire
Number of subjects: 200
Study 34987499 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMC cultures from CF+ group at 6 months
Number of subjects: 200
Study 34987499 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma analysis at 6 months
Number of subjects: 200
Study 32003737 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight-loss program (IWLP)
Number of subjects: 42
Study 35580621 — intervention group
Group type: EXPERIMENTAL
Intervention: Displaying cost and turnaround time (TAT) for reference laboratory tests at the time of order entry in the electronic health record (EHR) system
Number of subjects: 0
Study 35580621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no display of cost and TAT)
Number of subjects: 0
Study 34879449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab (100 mg for those weighing ≤30 kg and 200 mg for those weighing >30 kg)
Number of subjects: 408
Study 34879449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study 34879449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 408
Study 33563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant vaginal cuff brachytherapy
Number of subjects: 182
Study 33563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 182
Study 32271036 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling techniques for characterizing behavior from audio recordings
Number of subjects: 11
Study 35743988 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electric Nerve Stimulation (TENS)
Number of subjects: 80
Study 35743988 — intervention group
Group type: COMPARATOR
Intervention: Placebo-TENS
Number of subjects: 80
Study 35743988 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 80
Study 34022791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram incorporating lactate level
Number of subjects: 1986
Study 34022791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1986
Study 33023946 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab treatment
Number of subjects: 71
Study 33023946 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of CRP or IL6
Number of subjects: 71
Study 33023946 — intervention group
Group type: EXPERIMENTAL
Intervention: Other inflammatory markers outside of IL1β pathway
Number of subjects: 71
Study 33951633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week multimodal program for stress reduction (health coaching, relaxation, physical activity, balneotherapeutic elements)
Number of subjects: 96
Study 33951633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week multimodal program for stress reduction
Number of subjects: 96
Study 33951633 — intervention group
Group type: COMPARATOR
Intervention: Control group B
Number of subjects: 96
Study 33951633 — intervention group
Group type: COMPARATOR
Intervention: Control group C
Number of subjects: 96
Study 33744300 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-E You mobile health application
Number of subjects: 1360
Study 33744300 — intervention group
Group type: COMPARATOR
Intervention: Control group (iPads with sexual health questions)
Number of subjects: 1360
Study 36049660 — intervention group
Group type: EXPERIMENTAL
Intervention: Upward comparison condition
Number of subjects: 0
Study 36049660 — intervention group
Group type: COMPARATOR
Intervention: Downward comparison condition
Number of subjects: 0
Study 34550072 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-MRI app
Number of subjects: 84
Study 34550072 — intervention group
Group type: COMPARATOR
Intervention: Standard Preparatory Manual (SPM)
Number of subjects: 84
Study 34550072 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Life Program (CLP)
Number of subjects: 84
Study 33267925 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPH EROS (7.5 mL of 2.5 mg/mL, equivalent to 18.8 mg of amphetamine base)
Number of subjects: 30
Study 33267925 — intervention group
Group type: COMPARATOR
Intervention: ER MAS (30 mg capsule, equivalent to 18.8 mg of amphetamine base)
Number of subjects: 30
Study 32034912 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic closed-loop stimulation during sleep
Number of subjects: 29
Study 32034912 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (placebo control)
Number of subjects: 29
Study 33341413 — intervention group
Group type: EXPERIMENTAL
Intervention: DISCO intervention group (systematic follow‐up by a dietitian to adhere to the Dietary Approaches to Stop Hypertension nutrition model together with optimal medical therapy [OMT])
Number of subjects: 92
Study 33341413 — intervention group
Group type: COMPARATOR
Intervention: Control group (OMT alone)
Number of subjects: 92
Study 33418231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on nutritional and inflammatory indicators for overall survival (OS) prediction
Number of subjects: 93
Study 33418231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on nutritional and inflammatory indicators for disease-free survival (DFS) prediction
Number of subjects: 93
Study 33418231 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group based on nomogram
Number of subjects: 93
Study 33418231 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery in high-risk group
Number of subjects: 93
Study 32805740 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 LC-PUFAs (1 g of fish oil 3 times a day for 2 months containing 360 mg EPA and 240 mg DHA)
Number of subjects: 6
Study 35085341 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise and dietary lifestyle intervention (n = 16)
Number of subjects: 32
Study 35085341 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care management (n = 16)
Number of subjects: 32
Study 34115731 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance intervention (n = 20)
Number of subjects: 39
Study 34115731 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (n = 19)
Number of subjects: 39
Study 34115731 — intervention group
Group type: COMPARATOR
Intervention: Dance and exercise interventions
Number of subjects: 39
Study 34115731 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 39
Study 32707001 — intervention group
Group type: EXPERIMENTAL
Intervention: MRG-110 (0.01 to 1.5 mg/kg body weight)
Number of subjects: 0
Study 32707001 — intervention group
Group type: EXPERIMENTAL
Intervention: MRG-110 (1.5 mg/kg)
Number of subjects: 0
Study 32707001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35263681 — intervention group
Group type: EXPERIMENTAL
Intervention: holoBLG lozenge
Number of subjects: 51
Study 35263681 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 51
Study 33441157 — intervention group
Group type: EXPERIMENTAL
Intervention: Qing‐Chang‐Hua‐Shi granule (QCHS)
Number of subjects: 120
Study 33441157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32745734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/d) plus Clopidogrel (75 mg/d) for 6 months followed by random assignment to aspirin plus clopidogrel for an additional 6 months
Number of subjects: 480
Study 32745734 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg/d) plus Placebo for an additional 6 months
Number of subjects: 480
Study 32745734 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/d) plus Placebo for an additional 6 months
Number of subjects: 480
Study 34755919 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive computerised working memory training (WMT)
Number of subjects: 72
Study 34755919 — intervention group
Group type: COMPARATOR
Intervention: Non-adaptive control working memory training (placebo)
Number of subjects: 72
Study 34081322 — intervention group
Group type: EXPERIMENTAL
Intervention: Gleason 6 out of 10 prostate cancer
Number of subjects: 718
Study 34081322 — intervention group
Group type: COMPARATOR
Intervention: Grade group 1 out of 5 prostate cancer
Number of subjects: 718
Study 34081322 — intervention group
Group type: COMPARATOR
Intervention: Indolent lesion of epithelial origin
Number of subjects: 718
Study 32708355 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal component 1 (diabetes, heart disease, and hypertension)
Number of subjects: 10217
Study 32708355 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal component 3 (psychiatric and cerebrovascular diseases)
Number of subjects: 10217
Study 32708355 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal component 4
Number of subjects: 10217
Study 32708355 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal component 4 among participants aged 45-64 years
Number of subjects: 10217
Study 35130348 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscrew-supported palatal crib (MSPC)
Number of subjects: 26
Study 35130348 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixed palatal crib (CFPC)
Number of subjects: 26
Study 33142016 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576
Study 33142016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 35710395 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training with post-exercise sauna treatments (ET + S, n = 8)
Number of subjects: 15
Study 35710395 — intervention group
Group type: COMPARATOR
Intervention: Exercise training without sauna treatments (ET, n = 7)
Number of subjects: 15
Study 34321144 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA, NuSmile® NeoMTA®)
Number of subjects: 50
Study 34321144 — intervention group
Group type: COMPARATOR
Intervention: Ferric Sulfate (FS)
Number of subjects: 50
Study 33213400 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help ACT-training
Number of subjects: 290
Study 33213400 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 290
Study 33213400 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal hair cortisol concentrations
Number of subjects: 290
Study 33213400 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews
Number of subjects: 290
Study 35324342 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (N = 166)
Number of subjects: 341
Study 35324342 — intervention group
Group type: COMPARATOR
Intervention: No surgical intervention (N = 175)
Number of subjects: 341
Study 35598636 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component edetate disodium (Na2EDTA)‐based chelation solution, 40 weekly infusions
Number of subjects: 1000
Study 35598636 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily oral, high-dose multivitamin and mineral supplements
Number of subjects: 1000
Study 35598636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group for chelation therapy)
Number of subjects: 1000
Study 35598636 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group for multivitamin and mineral supplements)
Number of subjects: 1000
Study 33570248 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 0
Study 33570248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33264811 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 496
Study 33264811 — intervention group
Group type: COMPARATOR
Intervention: Hot Snare Polypectomy (HSP)
Number of subjects: 496
Study 33832572 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact 754 ventilator
Number of subjects: 4
Study 33832572 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact 731 ventilator
Number of subjects: 4
Study 33832572 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton‐T1 ventilator
Number of subjects: 4
Study 33832572 — intervention group
Group type: EXPERIMENTAL
Intervention: SAVe II ventilator
Number of subjects: 4
Study 33832572 — intervention group
Group type: EXPERIMENTAL
Intervention: All ventilators tested
Number of subjects: 4
Study 32618115 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBIND intervention (specialized behavioural training plus a tablet-based mHealth application)
Number of subjects: 1191
Study 32618115 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) ORW training
Number of subjects: 1191
Study 34180370 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence strategies delivered over five sessions
Number of subjects: 52
Study 34180370 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital care and home exercise program (Control)
Number of subjects: 52
Study 33814435 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline anemia (anemiav1)
Number of subjects: 213
Study 33814435 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline RDW (RDWv1)
Number of subjects: 213
Study 36028775 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutrition therapy (five in person visits and three phone calls) and freely delivered energy- and protein-rich foods
Number of subjects: 106
Study 36028775 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 106
Study 36028775 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutrition therapy
Number of subjects: 106
Study 33651970 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional Training Ward MIA
Number of subjects: 0
Study 33651970 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study 32812964 — intervention group
Group type: EXPERIMENTAL
Intervention: AOB‐w (350 mg)
Number of subjects: 0
Study 32812964 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 34018342 — intervention group
Group type: EXPERIMENTAL
Intervention: Luvadaxistat 75 mg BID
Number of subjects: 67
Study 34018342 — intervention group
Group type: EXPERIMENTAL
Intervention: Luvadaxistat 300 mg BID
Number of subjects: 67
Study 34018342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67